{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:05:25Z","timestamp":1790143525180,"version":"4.0.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research (NIHR)","doi-asserted-by":"crossref","award":["RP-PG- 0606-1049"],"award-info":[{"award-number":["RP-PG- 0606-1049"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research (NIHR)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000691","name":"Academy of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institute"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.psyneuen.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T12:07:02Z","timestamp":1536408422000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis"],"prefix":"10.1016","volume":"99","author":[{"given":"Maria Antonietta","family":"Nettis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Pergola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kolliakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Bonaccorso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Gaughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Di Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago Reis","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bertolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine M.","family":"Pariante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Dazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2018.09.005_bib0005","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.metabol.2009.11.014","article-title":"Current concepts in triglyceride metabolism, pathophysiology, and treatment","volume":"59","author":"AbouRjaili","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0010","series-title":"Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naive First-Episode Schizophrenia","author":"Anhoj","year":"2018"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0015","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1192\/bjp.184.2.110","article-title":"Causal association between cannabis and psychosis: examination of the evidence","volume":"184","author":"Arseneault","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1186\/s12888-016-1143-8","article-title":"Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder","volume":"16","author":"Bai","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00127-014-0887-z","article-title":"Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors","volume":"49","author":"Baumeister","year":"2014","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0030","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1399-5618.2009.00730.x","article-title":"Can body mass index help predict outcome in patients with bipolar disorder?","volume":"11","author":"Calkin","year":"2009","journal-title":"Bipolar Disord."},{"issue":"Suppl 1","key":"10.1016\/j.psyneuen.2018.09.005_bib0035","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1093\/schbul\/sbv173","article-title":"Brain biomarkers of vulnerability and progression to psychosis","volume":"42","author":"Cannon","year":"2016","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fncel.2015.00040","article-title":"Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis","volume":"9","author":"Cattaneo","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0045","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.psychres.2013.08.056","article-title":"Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia","volume":"210","author":"Chen","year":"2013","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0050","first-page":"018","article-title":"Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis","volume":"9","author":"Chouinard","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0055","first-page":"20","volume":"vol. 13","author":"Corner","year":"2009"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0060","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jamapsychiatry.2014.1314","article-title":"Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study","volume":"71","author":"Correll","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","article-title":"Serum and gene expression profile of cytokines in first-episode psychosis","volume":"31","author":"Di Nicola","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0070","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/cercor\/bhx008","article-title":"Elevated body mass index is associated with increased integration and reduced cohesion of sensory-driven and internally guided resting-state functional brain networks","volume":"28","author":"Doucet","year":"2018","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0075","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: the linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch. Med. Sci. AMS"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1176\/appi.ajp.160.1.112","article-title":"Obesity as a correlate of outcome in patients with bipolar I disorder","volume":"160","author":"Fagiolini","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0085","first-page":"308","article-title":"Correlation of CRP, fasting serum triglycerides and obesity as cardiovascular risk factors","volume":"24","author":"Firdous","year":"2014","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00406-017-0771-4","article-title":"Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort","volume":"267","author":"Fond","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0095","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/schbul\/sbr134","article-title":"Neuroanatomical maps of psychosis onset: voxel-wise meta-analysis of antipsychotic-naive VBM studies","volume":"38","author":"Fusar-Poli","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0100","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1176\/appi.ajp.2009.09060802","article-title":"International consensus study of antipsychotic dosing","volume":"167","author":"Gardner","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2215-0366(15)00213-8","article-title":"Mental health starts with physical health: current status and future directions of non-pharmacological interventions to improve physical health in first-episode psychosis","volume":"2","author":"Gates","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0110","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1017\/S0033291711002947","article-title":"Childhood maltreatment is associated with increased body mass index and increased C-reactive protein levels in first-episode psychosis patients","volume":"42","author":"Hepgul","year":"2012","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0115","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.schres.2015.08.019","article-title":"Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups","volume":"168","author":"Joseph","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/0269881111431622","article-title":"The metabolic syndrome in schizophrenia: is inflammation a contributing cause?","volume":"26","author":"Leonard","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0125","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1038\/sj.npp.1301325","article-title":"Defining\u2019 response\u2019 in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs","volume":"32","author":"Leucht","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pnpbp.2017.03.020","article-title":"Investigating the link between drug-naive first episode psychoses (FEPs), weight gain abnormalities and brain structural damages: relevance and implications for therapy","volume":"77","author":"Minichino","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.schres.2017.03.031","article-title":"Lipid profile disturbances in antipsychotic-naive patients with first-episode non-affective psychosis: a systematic review and meta-analysis","volume":"190","author":"Misiak","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0140","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","article-title":"Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis","volume":"41","author":"Mondelli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0145","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S2215-0366(17)30101-3","article-title":"Brain microglia in psychiatric disorders","volume":"4","author":"Mondelli","year":"2017","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"10.1016\/j.psyneuen.2018.09.005_bib0150","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/1570159X16666180119144538","article-title":"Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review","volume":"16","author":"Orsolini","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1744-9081-9-27","article-title":"Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study","volume":"9","author":"Park","year":"2013","journal-title":"Behav. Brain Funct."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0160","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.psychres.2015.07.041","article-title":"Parameters of glucose and lipid metabolism at the fasted state in drug-naive first-episode patients with psychosis: evidence for insulin resistance","volume":"229","author":"Petrikis","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0165","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1001\/jamapsychiatry.2016.3803","article-title":"Impaired glucose homeostasis in first-episode schizophrenia: a systematic review and meta-analysis","volume":"74","author":"Pillinger","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1192\/bjp.bp.117.200907","article-title":"Cholesterol and triglyceride levels in first-episode psychosis: systematic review and meta-analysis","volume":"211","author":"Pillinger","year":"2017","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3389\/fpsyt.2014.00137","article-title":"Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions","volume":"5","author":"Ringen","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbi.2015.06.004","article-title":"Inflammation and metabolic changes in first episode psychosis: preliminary results from a longitudinal study","volume":"49","author":"Russell","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbalip.2011.10.011","article-title":"Fish oil \u2013 how does it reduce plasma triglycerides?","volume":"1821","author":"Shearer","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0190","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s12888-016-1006-3","article-title":"Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study","volume":"16","author":"Solberg","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0195","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1001\/archgenpsychiatry.2009.12","article-title":"Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis","volume":"66","author":"Takahashi","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.psyneuen.2017.02.035","article-title":"Depression and anxiety both associate with serum level of hs-CRP: a gender-stratified analysis in a population-based study","volume":"81","author":"Tayefi","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"Suppl. 1","key":"10.1016\/j.psyneuen.2018.09.005_bib0205","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1038\/ijo.2013.95","article-title":"Gender differences in the relationship between symptoms of depression and high-sensitivity CRP","volume":"37","author":"Vetter","year":"2013","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0210","doi-asserted-by":"crossref","first-page":"75445","DOI":"10.18632\/oncotarget.17995","article-title":"Association between C-reactive protein and risk of schizophrenia: an updated meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0215","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.smim.2015.10.006","article-title":"Interactions between adipose tissue and the immune system in health and malnutrition","volume":"27","author":"Wensveen","year":"2015","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/08039488.2014.984755","article-title":"Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder","volume":"69","author":"Wysokinski","year":"2015","journal-title":"Nord. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0225","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000356536","article-title":"First-episode psychosis: an inflammatory state?","volume":"21","author":"Zajkowska","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.psyneuen.2018.09.005_bib0230","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1beta: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018303986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453018303986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:02:31Z","timestamp":1759683751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453018303986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":46,"alternative-id":["S0306453018303986"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.09.005","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}